跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
Anticoagulants for acute ischaemic stroke.
G. Gubitz
, C. Counsell, P. Sandercock, D. Signorini
科研成果
:
期刊稿件
›
文献综述
›
同行评审
130
引用 (Scopus)
综述
指纹
指纹
探究 'Anticoagulants for acute ischaemic stroke.' 的科研主题。它们共同构成独一无二的指纹。
分类
加权
按字母排序
Keyphrases
Acute Ischemic Stroke
100%
Anticoagulant Therapy
100%
Anticoagulants
100%
Blood Clot
16%
Clot
16%
Cochrane
16%
Confidence Interval
33%
Disability
16%
Drug Companies
16%
Early Treatment
16%
Extracranial Hemorrhage
16%
Heparinoid
16%
Impact on Patients
16%
Ischemic Stroke
33%
Long-term Benefit
16%
Low Molecular Weight Heparin
16%
Net Benefit
16%
Non-associated
16%
Odds Ratio
33%
Oral Anticoagulants
16%
Patient Characteristics
16%
Patient Survival
16%
Pulmonary Embolism
16%
Randomized Trial
16%
Recurrent Ischemic Stroke
16%
Sensitivity Analysis
16%
Stroke Onset
16%
Stroke Recurrence
16%
Symptomatic Intracerebral Hemorrhage (sICH)
16%
Thrombin Inhibitor
16%
Trial Quality
16%
Unfractionated Heparin
16%
Medicine and Dentistry
Anticoagulant
100%
Anticoagulant Therapy
85%
Antithrombotic
42%
Apoplexy
42%
Artery
14%
Bleeding
14%
Blood Clot
14%
Brain Ischemia
100%
Cerebral Hemorrhage
14%
Direct Thrombin Inhibitor
14%
Group Trial
14%
Heparin
14%
Heparinoid
14%
Low Molecular Weight Heparin
14%
Odds Ratio
28%
Patient Characteristics
14%
Pulmonary Embolism
14%
Recurrent Disease
14%
Nursing and Health Professions
Anticoagulant Agent
100%
Anticoagulant Therapy
85%
Bleeding
14%
Brain Hemorrhage
14%
Brain Ischemia
100%
Confidence Interval
28%
Heparin
14%
Heparinoid
14%
Low Molecular Weight Heparin
14%
Lung Embolism
14%
Odds Ratio
28%
Recurrent Disease
14%
Thrombin Inhibitor
14%
Neuroscience
Anticoagulant
88%
Antithrombotic
100%
Brain Ischemia
100%
Cerebral Hemorrhage
11%
Direct Thrombin Inhibitor
11%
Heparin
11%
Heparinoid
11%
Low Molecular Weight Heparin
11%
Pulmonary Embolism
11%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Bleeding
7%
Brain Hemorrhage
7%
Brain Ischemia
100%
Group Trial
7%
Heparin
7%
Heparinoid
7%
Low Molecular Weight Heparin
7%
Lung Embolism
7%
Recurrent Disease
7%
Thrombin Inhibitor
7%